Yes and no, and the difference is the whole answer. Semaglutide is FDA-approved as the active ingredient in specific branded products, for specific uses. Compounded semaglutide is not FDA-approved. telos rx offers compounded semaglutide, so that second sentence applies to what we do, and we say it plainly rather than blur it.
The molecule is approved. The compounded version is not. Both things are true at once, and any company that tells you otherwise is selling you something. Every prescription is subject to medical approval by a licensed provider.
Start your intake →The two halves of the answer
Most articles on this question pick a half and run with it. One camp says "semaglutide is FDA-approved," full stop. The other says "compounded semaglutide is illegal," also full stop. Neither is right.
Here is the accurate version, in two sentences.
- Half one. Semaglutide is the approved active ingredient in several branded prescription products sold in the US.
- Half two. Compounded semaglutide is not FDA-approved. It is a different thing, prepared a different way, under a different part of federal law.
Keep those separate and the rest of this page makes sense.
Which semaglutide products are FDA-approved
Three branded product families containing semaglutide are approved in the United States. All are Novo Nordisk trademarks. We name them here only to describe the regulatory record. telos rx does not sell them.
- Ozempic injection. Approved December 5, 2017 under NDA 209637. Labeled for glycemic control in adults with type 2 diabetes. Its label also covers cardiovascular risk reduction in that group.
- Rybelsus tablets. Approved September 20, 2019 under NDA 213051. Oral semaglutide, labeled for type 2 diabetes. Oral tablets branded Ozempic now sit under the same application.
- Wegovy injection. Approved June 4, 2021 under NDA 215256. Labeled for chronic weight management. Its label also covers cardiovascular risk reduction in adults with obesity or overweight.
You can check every one of these yourself in Drugs@FDA, the agency's public approval database. Application numbers and approval dates above come straight from it.
Note what those approvals cover. A named product, from a named manufacturer, at named strengths, in named packaging, for named uses. Approval is granted to a product, not to a molecule in the abstract.
What FDA approval actually certifies
This is the part people skip, and it is the part that makes the rest coherent.
An FDA approval is the end of a long evidence process. A sponsor files an investigational application, runs phase 1, 2 and 3 clinical trials, and submits the results. FDA reviewers examine the trial design, the effectiveness data, the side effect profile, and the conditions under which the drug is manufactured. The agency's own summary of that process is worth reading: The FDA's Drug Review Process.
So approval certifies three things about one specific product. That the evidence supports the labeled use. That the known risks are acceptable against that benefit. That the manufacturing meets federal quality standards.
It does not certify the ingredient everywhere the ingredient appears. That distinction is the entire reason the second half of the answer exists.
Two details are worth pinning down. An approval is tied to a manufacturing process at a named facility, not just to a formula. It is also tied to a label. That label sets the strength, the dosing schedule, the warnings, and the population studied.
Change any of those and you are outside what the approval covered. This is why "semaglutide is FDA-approved" is a sloppy sentence on its own. Approved in what, at what strength, for whom?
Those questions have answers for a branded product. They have no answer for a molecule considered in the abstract.
Key takeaway: FDA approves products, not molecules. A branded semaglutide product carrying an approval says nothing about a compounded one.
Compounded semaglutide is not FDA-approved
Said again, because it matters more than anything else on this page. Compounded semaglutide is not FDA-approved.
Every telehealth company offering it should tell you the same thing in the same words: compounded semaglutide is not FDA-approved. We put it in the first line of this page for that reason.
The FDA is direct about what that means. On its compounding Q&A the agency writes that compounded drugs are not FDA-approved, and that "FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." On its GLP-1 page it repeats the point for this drug class specifically.
So there is no premarket review file behind a compounded preparation. No approval letter. No agency sign-off on the strength, the container, or the titration schedule. That is a real difference, and you should weigh it before you start anything.
The FDA also notes that a compounded drug "might be appropriate if a patient's medical need cannot be met by an FDA-approved drug." That is the door compounding walks through, and it is a narrow one by design.
What compounding is, and how it is regulated
Compounding is the practice of a licensed pharmacist preparing a medication for one identified patient, rather than manufacturing standardized units for a mass market. It is old, ordinary pharmacy work. A child who cannot swallow a tablet gets a liquid. A patient allergic to a dye gets the same drug without it.
The mechanics are specific, and the specifics are the safeguard. A licensed prescriber writes a valid prescription for a named individual. A licensed compounding pharmacy prepares that medication for that person. Bulk substances have to meet an applicable USP monograph.
Nothing is prepared speculatively for whoever happens to turn up. Federal compounding regulations set those conditions, and there is no version of them that skips the prescription.
Oversight is split. Day to day supervision of state-licensed pharmacies sits with state boards of pharmacy, while the FDA conducts surveillance and for-cause inspections. The agency lays out that division in Compounding and the FDA: Questions and Answers.
Here is the part that trips people up. Federal law does not pretend a compounded medication is approved. It sets the conditions under which one may lawfully be prepared without an approval behind it.
Lawfully prepared and FDA-approved are two different statuses. A compounded preparation can be the first without ever being the second. Anyone who collapses those two into one is not being straight with you.
Why people still ask about compounded semaglutide
Because the branded products are expensive, insurance coverage is patchy, and a lot of people fall outside it. A provider may also decide a standard commercial strength is not the right fit for an individual patient.
None of that changes the regulatory facts above. It just explains why the question keeps getting asked. If you want the fuller picture on the compounded side, read what compounded semaglutide is and how semaglutide works in the body.
How telos rx handles this
We do not soften it. Our compounded semaglutide is compounded, not FDA-approved. It is prepared by a licensed US compounding pharmacy against a valid prescription written for you, under federal compounding regulations.
The process is asynchronous and online. You complete an intake in about five minutes. A US-licensed provider reviews your history, usually within hours. There is no appointment to book, and no prescription is automatic. Any medication is subject to medical approval by a licensed provider.
Pricing is published rather than gated behind a quiz.
- Compounded semaglutide, as low as $99 per month
- Compounded tirzepatide, as low as $139 per month
- Needle-free oral tirzepatide, as low as $129 per month
- Microdosed tirzepatide, as low as $116 per month
telos rx is LegitScript-certified. You get unlimited care-team messaging, dose adjustments, and quarterly labs. You can cancel anytime, and FSA and HSA funds are eligible.
Start your online visit and a licensed provider will review whether any of this is appropriate for you.
Questions worth asking any provider
Whoever you use, ask these before you pay.
- Is what you are sending me FDA-approved, yes or no?
- Which licensed pharmacy compounds it, and in which state?
- What strength am I receiving, and what am I measuring per dose?
- Who reviews my medical history, and are they licensed in my state?
- What happens if I have a side effect at 9pm on a Sunday?
A company that dodges the first question is telling you something. The FDA lists one specific telehealth red flag here. A company claiming the compounded drug is the same as an FDA-approved drug.
Frequently Asked Questions
Is semaglutide FDA approved?
Semaglutide is FDA-approved as the active ingredient in specific branded products. Ozempic injection was approved in 2017, Rybelsus tablets in 2019, and Wegovy injection in 2021, each for the uses on its own label. Those are Novo Nordisk products.
Is compounded semaglutide FDA-approved?
No. Compounded semaglutide is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed.
If it is not FDA-approved, is compounded semaglutide legal?
Legal and approved are separate questions. Federal compounding regulations allow a licensed compounding pharmacy to prepare a medication against a valid prescription written for an identified individual patient. That is a different pathway from FDA approval, and it is not a substitute for one.
Does telos rx sell Ozempic or Wegovy?
No. Those are Novo Nordisk brands and we do not sell them. telos rx offers compounded semaglutide and compounded tirzepatide, which are not FDA-approved.
Does the FDA test compounded semaglutide before it ships?
No. There is no FDA premarket review of a compounded preparation. State boards of pharmacy handle day to day oversight of state-licensed pharmacies, and the FDA conducts surveillance and for-cause inspections.
How much does compounded semaglutide cost at telos rx?
Compounded semaglutide is as low as $99 per month, with pricing published upfront. Any prescription is subject to medical approval by a licensed provider, and approval is not guaranteed.
telos rx is LegitScript-certified. Compounded medications are compounded, not FDA-approved, and are prepared under federal compounding regulations by licensed US pharmacies. Ozempic, Rybelsus and Wegovy are registered trademarks of Novo Nordisk A/S, referenced here descriptively only. telos rx is not affiliated with Novo Nordisk and does not sell those products. Any prescription is subject to medical approval by a licensed provider; approval is never automatic or guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service. This page is general information, not medical advice.
Start your private evaluation at telos rx, or begin your online visit now.